Drug Discovery World

FEBRUARY 7, 2023

Download our new whitepaper ‘From bench to billions: A guide to facilitating scale-up of adherent cultures for cell and gene therapies’, brought you by Corning. Given the potential of emerging advanced therapies, market demand is likely to continue to grow.

Gene Therapy 52

Gene Therapy Gene Drugs Marketing 52

Drug Discovery World

OCTOBER 19, 2022

Download the new whitepaper from Mirus Bio : Electroporation Made Easy for Hard-to-Transfect Cells. The post Whitepaper: Electroporation Made Easy for Hard-to-Transfect Cells appeared first on Drug Discovery World (DDW). Optimising electroporation with the Ingenio(R) EZporator(R) Electroporation System. Download now.

Gene 52

Gene Drugs 52

Intouch Solutions

OCTOBER 27, 2020

NEW YORK, NY (October 27, 2020) Intouch Media announced it has released a new whitepaper, “Future State: The New Media Landscape,” that explores and provides guidance on four critical media industry trends -- the rise of automatic content recognition, addressable TV, privacy versus personalization and the cookieless future.

91

91

Drug Discovery World

MARCH 27, 2023

The post New whitepaper: Take a deep dive into cell therapy appeared first on Drug Discovery World (DDW).

Reagent 52

Reagent Manufacturing Development Drugs 52

Intouch Solutions

JULY 16, 2021

A recent whitepaper from Veeva, Intouch, and a few other agencies, titled “Getting Ready for Modular Content: An Agency Perspective,” explains how: by using modular content. Graphic from Veeva whitepaper , “ Getting Ready for Modular Content: An Agency Perspective.”

Marketing 52

Marketing Development 52

BioTech 365

MAY 27, 2021

Whitepaper: Advancing Drug Discovery Through DNA Encoded Library Technology! Whitepaper: Advancing Drug Discovery Through DNA Encoded Library Technology! Available Now! Available Now!

DNA 40

DNA Drugs 40

Intouch Solutions

JANUARY 5, 2021

The Now & The Next in Pharma Marketing Offers Real-World Solutions Brands Can Start Implementing Today NEW YORK, NY (January 5, 2021) -- The DHC Group and Intouch Group announced that, together, they have published a new whitepaper titled The Now & The Next in Pharma Marketing. Areas covered include?evolving

Branding 52

Branding Marketing 52

Antidote

MARCH 21, 2024

Though it normally begins with mild memory loss, Alzheimer’s disease is a progressive condition that will eventually develop into a severely life-altering affliction. Alzheimer’s disease is the most common type of dementia , estimated to impact more than 6 million Americans, most of whom are over the age of 65.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Development 52

Antidote

AUGUST 3, 2023

Primary biliary cholangitis (PBC) is a rare, chronic liver disease that impacts 58 out of every 100,000 women and 15 out of every 100,000 men in the United States.

52

52

Antidote

JANUARY 24, 2024

Multiple sclerosis, often shortened to MS, is an autoimmune disorder that causes the body to attack the central nervous system.

52

52

Antidote

AUGUST 23, 2023

Rheumatoid arthritis, also known as RA, is a chronic, autoimmune disease that primarily impacts the joints. It impacts 1.5 million people in the United States, with women being three times more likely to develop the condition.

Development 52

Development 52

Antidote

APRIL 11, 2023

Asthma is a condition that can impact anyone — and currently, it affects over 26.5 million people in the United States. In spite of available treatments, asthma is responsible for 1.3 million emergency room visits and over 3,500 deaths every year.

52

52

Antidote

SEPTEMBER 19, 2023

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that results in weakened breathing and reduced lung function. In the U.S., it is estimated that 50,000 individuals are diagnosed with IPF each year, and 140,000 are estimated to live with the disease in America.

52

52

Antidote

MAY 11, 2023

Cardiovascular disease (CVD) refers to a group of disorders that affect the heart and blood vessels. Heart diseases are the leading cause of death in the United States, and it is estimated that a CVD-related fatality happens every 34 seconds.

52

52

Antidote

DECEMBER 6, 2022

At Antidote, we understand that successfully engaging patients for a clinical trial starts with a deep understanding of the patient population. Knowing who patients are, what motivates them, and what messages will resonate with them can all be beneficial when finding individuals who may be eligible to take part in specific studies.

Clinical Trials 52

Clinical Trials Clinical Trials Trials 52

Antidote

OCTOBER 26, 2023

Type 1 diabetes (T1D) is a chronic, autoimmune disease that occurs when the body mistakenly attacks the pancreatic cells that create insulin. Without insulin, the body can’t process glucose, which can result in extreme blood sugar swings, excessive thirst and hunger, extreme fatigue, and more.

Insulin 52

Insulin 52

Antidote

MAY 23, 2023

Chronic kidney disease (CKD) is a medical condition that occurs when the kidneys experience a gradual loss of functioning that inhibits their ability to filter blood. It is estimated to impact over 37 million Americans, and millions more are at an increased risk.

52

52

Antidote

JUNE 23, 2023

Osteoarthritis (OA) is a condition associated with the gradual denigration of cartilage in the joints — and while it can occur anywhere in the body, the knee is one of the most common areas impacted. Current research estimates that 46% of people will develop knee OA in their lifetime.

Development 52

Development Research 52

Antidote

MARCH 21, 2023

Depression, also known as clinical depression, Major Depressive Disorder, or MDD, is estimated to impact one out of six adults at some point in their lifetime , making it one of the most common mental disorders in the United States. It is estimated that the cost of depression totals $100 billion annually.

52

52

Antidote

MARCH 9, 2023

Parkinson’s disease, a neurodegenerative brain disorder, impacts 10 million people across the world. Most commonly associated with tremors or shaking, it is a condition that significantly affects a person’s quality of life, and as of now, has no known cause.

52

52

Pharmaceutical Technology

DECEMBER 21, 2022

Free Whitepaper. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy. Editorial content is independently produced and follows the highest standards of journalistic integrity. By Cytiva Thematic.

Gene Therapy 351

Gene Therapy Vaccination Vaccine Manufacturing 351

Pharmaceutical Technology

DECEMBER 23, 2022

Free Whitepaper. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy. Editorial content is independently produced and follows the highest standards of journalistic integrity. By Cytiva Thematic.

Genetics 328

Genetics Medicine Development Gene Therapy 328

Antidote

FEBRUARY 9, 2023

Lupus is a chronic autoimmune disease that causes the body to attack its own tissues and organs. million people in the United States that live with the disease, it has severe implications — symptoms include pain, fatigue, hair loss, cognitive issues, physical impairments, and disfiguring rashes.

Research 52

Research 52

BioTech 365

OCTOBER 28, 2020

SAN FRANCISCO–(BUSINESS WIRE)–#ClinicalTrials—Perspectum’s new whitepaper clearly outlines how the upfront cost of pre-screening subjects for NASH clinical trial enrollment with non-invasive, MRI-based imaging biomarkers can be significantly offset by the costs saved due to the reduction in total number of … Continue reading (..)

Trials 52

Trials Clinical Trials Clinical Trials 52

Pharmaceutical Technology

FEBRUARY 23, 2023

Free Whitepaper Optimise your cell therapy process: a guide to cell thawing Typically carried out at the point of care, errors in cell therapy thawing could compromise treatment efficacy, leading to significant patient impact as well as high costs and a compromised reputation for the product’s developer.

Vaccination 289

Vaccination Vaccine Gene Therapy Manufacturing 289

Pharmaceutical Technology

DECEMBER 8, 2022

Free Whitepaper. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy. Editorial content is independently produced and follows the highest standards of journalistic integrity. By Cytiva Thematic.

Licensing 305

Licensing Licensing Gene Therapy Gene 305

BioTech 365

AUGUST 6, 2020

.–(BUSINESS WIRE)–Innophos, a leading international producer of nutritional specialty ingredients and custom-formulated solutions, today announced the release of its latest whitepaper and the launch of three additional Chelamax® products: Calcium Citrate, Zinc Picolinate and Bismalto Oxo Vanadium (BMOV).

Production 52

Production 52

Pharmaceutical Technology

JANUARY 17, 2023

Free Whitepaper. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy. Editorial content is independently produced and follows the highest standards of journalistic integrity. By Cytiva Thematic.

Development 276

Development Gene Therapy Antibody Gene 276

WCG Clinical

SEPTEMBER 7, 2023

Thank you for downloading our whitepaper. Whitepaper: Why Biotech Sponsors Need Outside Support Download The post Thank You for Downloading: Why Biotech Sponsors Need Outside Support appeared first on WCG. You can access it below or via your email.

52

52

WCG Clinical

SEPTEMBER 7, 2023

Thank you for downloading our whitepaper. Whitepaper: Is That Heart Attack Really an Adverse Event? You can access it below or via your email. Download The post Thank You for Downloading: Is That Heart Attack Really an Adverse Event? appeared first on WCG.

52

52

Pharmaceutical Technology

MARCH 20, 2023

Free Whitepaper Optimise your cell therapy process: a guide to cell thawing Typically carried out at the point of care, errors in cell therapy thawing could compromise treatment efficacy, leading to significant patient impact as well as high costs and a compromised reputation for the product’s developer.

Vaccination 245

Vaccination Vaccine Development Allergies 245

Pharmaceutical Technology

DECEMBER 18, 2022

Free Whitepaper. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy. Editorial content is independently produced and follows the highest standards of journalistic integrity. By Cytiva Thematic.

Gene Therapy 304

Gene Therapy Vaccination Vaccine Clinical Trials 304

Pharmaceutical Technology

MARCH 8, 2023

Free Whitepaper Optimise your cell therapy process: a guide to cell thawing Typically carried out at the point of care, errors in cell therapy thawing could compromise treatment efficacy, leading to significant patient impact as well as high costs and a compromised reputation for the product’s developer.

Gene Therapy 244

Gene Therapy Manufacturing Gene Production 244

Pharmaceutical Technology

MARCH 28, 2023

Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content.

Gene Editing 235

Gene Editing DNA Gene Gene Therapy 235

Pharmaceutical Technology

FEBRUARY 16, 2023

Free Whitepaper Optimise your cell therapy process: a guide to cell thawing Typically carried out at the point of care, errors in cell therapy thawing could compromise treatment efficacy, leading to significant patient impact as well as high costs and a compromised reputation for the product’s developer.

Development 242

Development Gene Therapy Gene Drugs 242

Antidote

DECEMBER 15, 2022

At Antidote, we believe that all members of society should be equally represented — especially when it comes to medical research. Historically, racial and ethnic minorities have been under-represented in the clinical trial space , and continue to face challenges when trying to access healthcare today.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Research 52

Pharmaceutical Technology

DECEMBER 5, 2022

Free Whitepaper. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy. Editorial content is independently produced and follows the highest standards of journalistic integrity. By Cytiva Thematic.

Research 246

Research Gene Therapy Vaccination Vaccine 246